H

Healius Ltd
ASX:HLS

Watchlist Manager
Healius Ltd
ASX:HLS
Watchlist
Price: 0.832 AUD -1.54%
Market Cap: 604.1m AUD

Intrinsic Value

The intrinsic value of one HLS stock under the Base Case scenario is 2.824 AUD. Compared to the current market price of 0.832 AUD, Healius Ltd is Undervalued by 71%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HLS Intrinsic Value
2.824 AUD
Undervaluation 71%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Healius Ltd

What is Valuation History?
Compare HLS to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
Bear Theses

Healius’s heavy reliance on government reimbursements for pathology and diagnostic imaging services poses a significant risk if future Medicare policy changes or cuts reduce revenue streams.

Bull Theses

Healius’s strong position in the Australian pathology sector, combined with cost optimization efforts, could yield competitive margins and sustainable growth even if parts of the healthcare budget tighten.

Show More Less
How do you feel about HLS?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Healius Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Healius Ltd

Current Assets 1B
Cash & Short-Term Investments 115.4m
Receivables 144.6m
Other Current Assets 778m
Non-Current Assets 2B
Long-Term Investments 1.8m
PP&E 968.8m
Intangibles 980.3m
Other Non-Current Assets 78.1m
Efficiency

Free Cash Flow Analysis
Healius Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Healius Ltd

Revenue
1.6B AUD
Cost of Revenue
-222.7m AUD
Gross Profit
1.3B AUD
Operating Expenses
-1.3B AUD
Operating Income
40.3m AUD
Other Expenses
-63.1m AUD
Net Income
-22.8m AUD
Fundamental Scores

HLS Profitability Score
Profitability Due Diligence

Healius Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin
Strong 3Y Average Gross Margin
Sustainable 3Y Average Operating Margin
Declining Gross Margin
37/100
Profitability
Score

Healius Ltd's profitability score is 37/100. The higher the profitability score, the more profitable the company is.

HLS Solvency Score
Solvency Due Diligence

Healius Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Short-Term Solvency
Average D/E
Positive Net Debt
37/100
Solvency
Score

Healius Ltd's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HLS Price Targets Summary
Healius Ltd

Wall Street analysts forecast HLS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HLS is 0.909 AUD with a low forecast of 0.707 AUD and a high forecast of 1.26 AUD.

Lowest
Price Target
0.707 AUD
15% Downside
Average
Price Target
0.909 AUD
9% Upside
Highest
Price Target
1.26 AUD
51% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for HLS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one HLS stock?

The intrinsic value of one HLS stock under the Base Case scenario is 2.824 AUD.

Is HLS stock undervalued or overvalued?

Compared to the current market price of 0.832 AUD, Healius Ltd is Undervalued by 71%.

Back to Top